$MRNA

MRNAModerna Inc.

YouTube 频道最近怎么谈 Moderna(MRNA)?

过去 30 天(截至 11-18),5 个 YouTube 频道谈到 Moderna(MRNA),共 10 条。最近一条:Schwab Network,2026-11-05。

本窗口内的全部观点与内容

截至 11-18
11-05
Schwab Network发布 2026-11-05
《The Big 3: HCA, ISRG, MRNA》
$MRNA中性
AI 摘要 · 说话者看好MRNA,理由是III期数据显示一款与Keytruda合作的药物使皮肤癌相关死亡减少约42%,且自今年年初以来呈上升趋势,但并非长期上升趋势。不过该股在255附近旧高点受阻,RSI在上升与下降趋势线之间方向未明;需突破任一侧才能明确看涨或看跌方向,若跌破238.25的5日EMA可能打开219。

你这里的下一个名字也属于医疗保健板块,但它是一家制药公司,跌幅比一些其他公司稍大,Moderna下跌了4.3%,今年迄今为止它经常登上头条。

Your last name here is also in the healthcare sector, but it's a pharmaceutical company that has fallen a little more than some of the others, down 4.3% for Moderna, which has been making headlines a lot so far this year.

Moderna的大局:大家都通过其新冠疫苗认识他们,但他们也在做一些很酷的事情,比如与Keytruda的合作,以及他们提供的一种已进入第三阶段的药物,目前显示它可以将皮肤癌相关死亡减少约42%。

所以,这是好消息。因此,我在长期趋势中看好Moderna,我不该说长期上升趋势。自今年年初以来,它一直处于上升趋势。

Well, the big picture for Moderna: everyone knows them from their COVID vaccine, but they also have some cool things they're working on, like the partnership with Keytruda and the drug they've provided that's reached Phase 3, which currently shows it can reduce skin cancer-related deaths by about 42%.

So, this is good news. So, I like Moderna in a long-term trend, I shouldn't say a long-term upward trend. It has been on an upward trend since the beginning of this year.

11-04
Meet Kevin发布 2026-11-04
《The Stock Market & Morning After Election 2026.》
$MRNA看涨
10-31
Meet Kevin发布 2026-10-31
《You've been WARNED.》
$MRNA看涨
10-30
Benzinga发布 2026-10-30
《$INTC Plunges 26%, $AMZN Drops 6% After Q3 Earnings | PreMarket Playbook | October 30, 2026》
$MRNA看跌
AI 摘要 · MRNA 不是一只值得持有的股票:它从未赚过钱,是一家“忽悠”公司,不过日内进出交易尚可。它此前表现强劲——上涨 545%,随后 William Blair 将其下调至 market perform——而 180 是良好的逢低买入点。

MRNA,只跌了几个点。

MRNA, only down a couple.

哇。MRNA。对。mRNA 在哪?mRNA 没有下跌。William Blair 对 Madna 股票出手,在上涨 545% 之后将评级下调至 market outperform。

那是 10 月 27 日,所以那不是,对,那看起来确实很强。

Wow. MRNA. Yeah. Where is mRNA? mRNA is not going down. William Blair takes a shot at Madna stock downgrade to market outperform after 545% run. That was October 27th, so that's not Yeah, that that looks strong for sure.

你觉得 MNA、MRNA 怎么样?它就是看起来不错。180 那次真是绝佳的逢低买入机会。我在 180 进场了。不过它从 240 因消息泄露而下跌时,我持有得不够久。那是一个很好的机会。

Uh, what do you think of MNA MRNA? It's just looking good. You know, that was such a buy the dip at 180. I got involved at 180. I didn't hold it long enough though when it went down from 240 on the leaked news. That was that was a good opportunity.

10-23
The Motley Fool发布 2026-10-23
《Moderna CEO Reveals His Massive Plans for Cancer, AI & Beyond!!》
$MRNA看涨
AI 摘要 · 主持人预计会继续加仓其Moderna持仓,认为市场对其平台定价有误:按行业通常10%的获批率,该股会被高估,但该平台应能提升其在每个新疾病领域的成功率,且自身免疫领域的价值尚未反映在股价中。

因为我们只有3个小时,我就直接开始提问了。好,我们先来解释一下 Moderna 的基础技术,用连一个讨厌科学的十年级学生都能听懂的方式来解释。

Since we only have 3 hours, I'll start asking questions right away. Okay, let's start by explaining Moderna's basic technology in a way that a tenth-grade student who hates science can understand.

哦,得了吧。高中时你不可能讨厌科学。很简单,正如你们很多人在疫情期间了解到的,信使RNA(mRNA)是一种信息分子。它由四个字母组成,就像所有软件都由0和1组成一样。

Oh, come on, man. You can't hate science in high school. Well, very simply, as many of you have learned during the pandemic, messenger RNA (mRNA) is an information molecule. It consists of four letters, just as all software consists of zeros and ones.

Schwab Network发布 2026-10-23
《Friday's First Moves: MRNA Cancer Vaccine Trial Leaks, DECK Earnings, NCLH Downgrade》引用来源:analysts
$MRNA中性
AI 摘要 · MRNA 下跌5.5%,起因是后期癌症疫苗阳性数据泄露(相较单用 Keytruda,复发/死亡风险相对降低42%)——这并非糟糕的结果。分析师认为这是“买传闻、卖新闻”:该股一年内上涨600%,已提前计入突破性进展,因此此次下跌看起来像是在官方三期结果公布前的获利了结。

Diane King Hall和我一起来看Moderna。我们昨天稍微谈过这个。昨天出现了一轮剧烈而戏剧性的抛售。

Diane King Hall is joining me to take a look at Moderna . We talked a little about this yesterday. It was an intense and dramatic sell-off yesterday.

昨天,这导致市值减少了240亿美元。Moderna今天仍面临压力。但这并不意味着业绩很差。这些压力出现在有关癌症疫苗试验的一些信息被泄露之后。我们原本预计它会在本周末发布。它仍计划在本周末发布。

Yesterday, this resulted in a $24 billion reduction in market value. There is ongoing pressure on Moderna today. But that doesn't mean the results were bad. These pressures come after some information regarding cancer vaccine trials was leaked .

We were expecting it to be released at the end of this week. It is still scheduled to be released at the end of this week.

他说在等
官方三期癌症疫苗结果发布
结果证实此前泄露的42%相对风险降低
本周末定于本周末发布的官方三期结果
支持这一观点:此次抛售是获利了结,而非数据不佳
Schwab Network发布 2026-10-23
《WDC & BE Slide After Earnings as Crude Crosses $100; MRNA Cancer Vaccine Data Leak》
$MRNA中性
AI 摘要 · Moderna 泄露的三期癌症疫苗数据显示,复发/死亡风险降低42%,而预期为40%;有人曾期待超过50%,且生存数据尚未泄露。股价下跌部分源于此前大幅上涨;说话者认为泄露的结果总体偏正面,仍有待本周末公布的最终结果。

好,接下来我们谈谈纳斯达克指数中的一只重要股票。不是今天,而是昨天。这家公司是Moderna。这与这里的科技股交易完全是两回事。在本周末将要发生的事情之前,市场情绪非常乐观。我们本应获得癌症疫苗试验的结果。

我们已经拿到了第一阶段和第二阶段的结果。昨天有一则消息泄露,导致股价下跌。请给我们讲讲这里正在发生的一些价格走势。

Okay, let's move on to talking about a big stock in the Nasdaq index. Not so much today, but yesterday. This is the company "Moderna". It's a completely different story from technology stock trading here.

There was a lot of optimism ahead of what would happen this weekend. We are supposed to get the results of the cancer vaccine trials. We have obtained the first stage and the second stage.

There was a leak yesterday that caused the stock to drop. Tell us about some of the price movements that are happening here.

他说在等
本周末公布的3期试验最终结果,包括生存数据
生存数据达到或超过部分投资者所期望的50%以上这一数字
本周末ESMO会议上公布的试验最终结果
支持说话者整体偏正面的解读
10-20
Meet Kevin发布 2026-10-20
《The NEXT Frontier: THESE 3 Stocks Boom》
$MRNA看涨
AI 摘要 · MRNA是值得长期看涨的持仓:AI将癌症靶点筛选从60天缩短至两周,使癌症治疗更快、更便宜。10月24日周六的3期临床数据发布是最近的催化剂,也可能令人失望;MRNA依赖这一单一疗法,糟糕的报告可能使其跌回底部。

Moderna 这个周六有一场会议。那将是一场演示,他们故意选在市场休市时进行。演示将在 10 月 24 日举行。这是最近的催化剂,即他们三期癌症治疗数据的更新。

Moderna has a meeting coming up this Saturday. It will be a presentation, and they deliberately do this when the market is closed. It will be a presentation on October 24th. This is the closest catalyst, an update to their Phase 3 cancer treatment data,

那么,Moderna 是做什么的?Moderna 基本上是说:“嘿,我们来检查某人的癌症。我们从癌症中取一个实体细胞,用手术切下一部分。我们做一次活检。”所以,我们要对癌细胞做活检。

然后,我们要做的是基因组测序……天哪。我们要对它做基因组测序,这是一长串基因数据。想想字母 T、A、C。还记得你学生物的时候吗?我们要做的是,在那个癌细胞里找到我们可以靶向摧毁的基因组部分,这当然意味着我们不想靶向那些一旦被靶向就可能杀死你的基因组部分。

显然,这是个问题。我们要靶向那个癌细胞独有的基因组部分。问题在于,癌细胞一直在突变,不断变化。因此,这个基础基因组变化很大。所以,我们要做的是靶向 32 个不同的部分。只要其中任何一个部分存活下来,我们仍然能够靶向那个癌细胞。

我们要做的是,把这些小部分注入你的体内,也许在 12 个月的疗程中注射七次。我们会训练你的身体。我们不会深入讲背后的确切科学,因为涉及蛋白质折叠以及预测淋巴结内最终会发生什么,会有点复杂。

简单说,有一些小载体,好吗?这些小载体将针对这 32 个部分接受训练。这 32 个小部分会被取来,附着在它的外表面。你把它带到你的淋巴系统,对它说:“你看到我们这里所有这些小凸起了吗?

消灭它们。消灭我们携带的这些小的蛋白质。识别它们并消灭它们。”然后你的淋巴系统会说:“我们不喜欢这个。我们要……我们要……我们要……做一个鬼脸。好了,一个鬼脸。我们要去追那些小凸起。”

这些凸起真的很难识别,而这就是人工智能的用武之地。因为它们可以游走你的全身,定位它们,追踪那个癌细胞并消灭它,防止它扩散到你身体的其他部位,对吧?整个思路是,即使那个癌细胞在突变或进化,只要我们还有那些剩余部分中的一个,我们仍然能识别它。

这就是思路。问题在于,这个筛选过程过去大约需要 60 天,而且你只能得到两个,也许只有两个部分。好吗?多亏了人工智能,这已经改变了。现在人工智能来了,说:“我们可以在大约两周内完成其中很多工作。”

我们可以得到 32 个预期芯片,我们确实相信它们会:第一,消灭癌症;第二,不会要你的命。这两件事都挺重要的,不是吗?因此,人工智能加快了这个过程所需的时间。

So, what does Moderna do? Moderna basically says: " Hey, let's examine someone's cancer. We'll take a solid cell from the cancer, and we'll surgically remove part of it. We'll take a biopsy."

So, we're going to take a biopsy of, you know, a cancer cell. And then, what we're going to do is genome sequencing...oh my god. We will be doing a genome sequence for that, which, as you know, is a very long series of genetic data.

Think of the letters T, A, and C. Remember your biology days, right? What we will try to do is try to find in that cancer cell parts of its genome that we can target to destroy it, which of course means that we do not want to target parts of that genome that, if targeted, could kill you.

Obviously, this is a problem. We want to target parts of that genome that are unique to that cancer cell . The problem is that cancer cells mutate all the time. It's constantly changing.

Therefore, this basic genome changes a lot. Therefore, what we will do is target 32 different parts. If any one of these parts survives, we will still be able to target that cancer cell.

What we will do is we will inject these small parts into your body, perhaps seven times over a 12-month course. We will train your body. We won't go into the exact science behind it, because it gets a bit complicated with protein folding and predicting what ultimately happens inside your lymph nodes.

Simply put, there are small carriers, okay? These small carriers will be trained on these thirty-two parts . These thirty-two small parts will be taken and attached to its outer surface.

You will take it to your lymphatic system and say to it, "Do you see all these little bumps we have here? Eliminate them. Eliminate these little proteins we are carrying. Identify them and eliminate them."

And then your lymphatic system will say: "We don't like this. We're going to ...we're going to ...we're going to... make a face. There we go . A face. We're going to go after those little bumps."

Well, these bumps are really hard to identify, and that's where artificial intelligence comes in. Because they can travel throughout your entire body, locate them, track down that cancerous cell and eliminate it to prevent it from spreading to the rest of your body, right?

The whole idea is that even if that cancer cell is mutating or evolving, as long as we have one of those remaining parts , we can still identify it. That's the idea. The problem is that this selection process used to take about 60 days, and you would only get two of them.

Maybe only two parts. Good? That has changed thanks to artificial intelligence. Now artificial intelligence comes along and says, "We can do a lot of this in about two weeks." We can get 32 expected chips that we actually believe will: first, eliminate cancer, and second, will not end your life.

Both things are somewhat important, aren't they? Therefore, artificial intelligence speeds up the time it takes to do this,

他说在等
10月24日周六报告会上的3期癌症治疗数据
确认该治疗取得成功的积极3期数据
10月24日10月24日周六报告会
支持看涨观点;若报告不佳则会削弱该观点
已显示 8 / 本页 10 条
看这只股票的全部记录